Acuta Capital Partners, LLC Gossamer Bio, Inc. Transaction History

Acuta Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.82 Million - $3.76 Million	252,500 Added 789.06%	284,500 $3.41 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $191,040 - $319,040	32,000 New	32,000 $268,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $1.01 Million - $1.5 Million	-119,843 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $962,988 - $1.34 Million	-95,157 Reduced 44.26%	119,843 $1.36 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $1.56 Million - $2.84 Million	215,000 New	215,000 $2.7 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $967,200 - $1.37 Million	-60,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $1.05 Million - $1.44 Million	60,000 New	60,000 $1.3 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.